INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Grant or awardVerified data

Gauthier Patricia G. reported DCOY

Director · Decoy Therapeutics Inc. · Common Stock

Side
A
Value
—
Shares
2,000
Price
—
Executed
Aug 31, 2026
Disclosed
Sep 2, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Aug 31 executedSep 2, 2026 disclosed

DCOY · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · DCOY

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    MK
    Marschel Peter KlausChief Business Officer
    DCOYDecoy Therapeutics Inc.
    Grant or award
    A—
    3,900 sh
    Aug 31, 2026Sep 2, 2026
    traded Aug 31, 2026
    +2dSEC FORM 4

    Evidence

    9
    HL
    Hibner Barbara LouiseChief Scientific Officer
    DCOYDecoy Therapeutics Inc.
    Grant or award
    A—
    4,216 sh
    Aug 31, 2026Sep 2, 2026
    traded Aug 31, 2026
    +2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002148287-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 31, 2026
    Published
    Sep 2, 2026
    Ingested by INSIDER
    Nov 5, 02:19 UTC
    Last re-read
    Nov 5, 02:19 UTC

    Extracted facts

    Filer
    Gauthier Patricia G.
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Decoy Therapeutics Inc.
    Ticker
    DCOY
    Shares
    2,000
    Price per share
    $0
    Execution date (reported)
    Aug 31, 2026
    Owned after transaction
    2,000 shares
    Days from execution to publication
    2

    What this establishes

    Gauthier Patricia G. filed this Form 4 reporting a grant or award of DCOY on Aug 31, 2026. It became public on Sep 2, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Gauthier Patricia G.cik:0002148287
    Issuer
    Decoy Therapeutics Inc.cik:0001615219

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.